通过分子动力学模拟和马尔科夫建模,揭示BRD9的体调节和约束机制
Bin Wang1, Jian Wang2, Wanchun Yang2
1Center for Medical Artificial Intelligence, Shandong University of Traditional Chinese Medicine, Qingdao 266112, China.
Molecules (Basel, Switzerland)
|August 10, 2024
概括
含基蛋白9 (BRD9) 抑制剂,POJ和82I,改变蛋白质结构和结合. 这项研究为癌症治疗策略的BRD9抑制提供了洞察力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 计算化学的计算化学
背景情况:
- 含基因的蛋白9 (BRD9) 涉及到染色体重塑,基因调节和癌症的发展.
- 抑制BRD9对向性癌症治疗有希望.
研究的目的:
- 研究全抑制剂POJ和正抑制剂82I与BRD9.9的结合机制.
- 通过这些抑制剂阐明BRD9的全调节.
- 为开发BRD9向癌症治疗提供理论基础.
主要方法:
- 分子动力学 (MD) 模拟.分子动力学 (MD) 模拟.
- 马尔科夫建模和主要组件分析.
- 有约束力的自由能量计算和马尔科夫流量分析.
主要成果:
- 抑制剂结合会诱导BRD9的显著结构变化,包括α-螺旋区域的改变.
- 马尔科夫流量分析在抑制剂结合时确定了ZA循环附近α-状度的变化.
- 和抑制剂的合作结合调节BRD9的结合能力和活性位点特征.
结论:
- 这项研究为BRD9.9上POJ和82I的抑制机制提供了新的见解.
- 这些发现支持开发双重向策略,以加强癌症治疗.
- 这项研究为未来针对BRD9.9的药物开发奠定了理论基础.
更多相关视频
13:57Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
Published on: February 18, 2014
29.3K
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
13.6K
相关概念视频
Cooperative Allosteric Transitions
2.3K
2.3K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Allosteric Regulation
57.8K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.8K
The Equilibrium Binding Constant and Binding Strength
12.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.8K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
